Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Foghorn Therapeutics Inc.
The company announced a restructuring, such as layoffs or closing a site. An 8-K is the notice a US public company must file within four business days of a major event.
foghorntx.comAI Executive Summary
AI-powered analysis of 8-K filing content
Foghorn Therapeutics and Eli Lilly terminated their collaboration on the Phase 1 trial of FHD-909, deciding not to advance into the expansion phase based on clinical data assessment. The company is reallocating resources to other portfolio programs with greater potential to address patient needs and create shareholder value.
Key Takeaways
FHD-909 Phase 1 trial collaboration with Eli Lilly has been terminated effective September 25, 2026
Clinical data assessment led to the decision not to advance the trial into the expansion phase
2 more takeaways
Filing Overview
What This Means
Foghorn Therapeutics Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.